Zurich Cantonal Bank
RNAM

Zurich Cantonal Bank’s Avidity Biosciences RNAM Stock Holding History

Zurich Cantonal Bank’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,122
Closed -$2.53M – 3329
2025
Q4 		$2.53M Buy
+35,122
New +$2.27M 0.01% 853

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $206M AUM 26.42% 1-Year Est. Return

Zurich Cantonal Bank's RNAM Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Avidity Biosciences (RNAM) in Q4 2025, closing a stake of 28,680 shares — an estimated $1.85M sold.

Zurich Cantonal Bank first reported a position in RNAM in Q3 2021 and held it in 17 quarters. The position peaked at $1.25M in Q3 2025. 343 funds tracked by Wall St. Rank hold RNAM as of Q4 2025.

  • Zurich Cantonal Bank reported no remaining Avidity Biosciences position as of Q4 2025 after selling out during the quarter.
  • Zurich Cantonal Bank sold 28,680 Avidity Biosciences shares in Q4 2025, an estimated $1.85M.
  • Zurich Cantonal Bank first reported a position in Avidity Biosciences in Q3 2021 and held it in 17 quarters.
  • Zurich Cantonal Bank's Avidity Biosciences position peaked at $1.25M in Q3 2025.
  • 343 funds tracked by Wall St. Rank held Avidity Biosciences as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.